nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—COMT—myometrium—ovarian cancer	0.00682	0.133	CbGeAlD
Entacapone—COMT—uterine cervix—ovarian cancer	0.0053	0.103	CbGeAlD
Entacapone—COMT—decidua—ovarian cancer	0.00505	0.0985	CbGeAlD
Entacapone—COMT—endometrium—ovarian cancer	0.0048	0.0935	CbGeAlD
Entacapone—COMT—gonad—ovarian cancer	0.00445	0.0867	CbGeAlD
Entacapone—COMT—uterus—ovarian cancer	0.00442	0.0862	CbGeAlD
Entacapone—COMT—female reproductive system—ovarian cancer	0.00397	0.0775	CbGeAlD
Entacapone—COMT—bone marrow—ovarian cancer	0.00375	0.0731	CbGeAlD
Entacapone—COMT—female gonad—ovarian cancer	0.00362	0.0705	CbGeAlD
Entacapone—COMT—vagina—ovarian cancer	0.00359	0.0701	CbGeAlD
Entacapone—COMT—testis—ovarian cancer	0.00321	0.0625	CbGeAlD
Entacapone—COMT—lymph node—ovarian cancer	0.00232	0.0453	CbGeAlD
Entacapone—Pollakiuria—Epirubicin—ovarian cancer	0.00072	0.000759	CcSEcCtD
Entacapone—Palpitations—Docetaxel—ovarian cancer	0.000712	0.00075	CcSEcCtD
Entacapone—Weight increased—Epirubicin—ovarian cancer	0.000709	0.000748	CcSEcCtD
Entacapone—Loss of consciousness—Docetaxel—ovarian cancer	0.000708	0.000746	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000706	0.000745	CcSEcCtD
Entacapone—Weight decreased—Epirubicin—ovarian cancer	0.000705	0.000743	CcSEcCtD
Entacapone—Hyperglycaemia—Epirubicin—ovarian cancer	0.000703	0.000741	CcSEcCtD
Entacapone—Cough—Docetaxel—ovarian cancer	0.000703	0.000741	CcSEcCtD
Entacapone—Angina pectoris—Doxorubicin—ovarian cancer	0.000703	0.000741	CcSEcCtD
Entacapone—Insomnia—Paclitaxel—ovarian cancer	0.000701	0.000739	CcSEcCtD
Entacapone—Pneumonia—Epirubicin—ovarian cancer	0.000699	0.000737	CcSEcCtD
Entacapone—Convulsion—Docetaxel—ovarian cancer	0.000698	0.000735	CcSEcCtD
Entacapone—Paraesthesia—Paclitaxel—ovarian cancer	0.000696	0.000734	CcSEcCtD
Entacapone—Hypertension—Docetaxel—ovarian cancer	0.000695	0.000733	CcSEcCtD
Entacapone—Dyspnoea—Paclitaxel—ovarian cancer	0.000691	0.000729	CcSEcCtD
Entacapone—Somnolence—Paclitaxel—ovarian cancer	0.000689	0.000727	CcSEcCtD
Entacapone—Myalgia—Docetaxel—ovarian cancer	0.000685	0.000723	CcSEcCtD
Entacapone—Chest pain—Docetaxel—ovarian cancer	0.000685	0.000723	CcSEcCtD
Entacapone—Nausea—Vinorelbine—ovarian cancer	0.000685	0.000722	CcSEcCtD
Entacapone—Dyspepsia—Paclitaxel—ovarian cancer	0.000682	0.000719	CcSEcCtD
Entacapone—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000681	0.000718	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000681	0.000718	CcSEcCtD
Entacapone—Conjunctivitis—Epirubicin—ovarian cancer	0.000676	0.000712	CcSEcCtD
Entacapone—Urinary tract infection—Epirubicin—ovarian cancer	0.000676	0.000712	CcSEcCtD
Entacapone—Dysuria—Doxorubicin—ovarian cancer	0.000674	0.000711	CcSEcCtD
Entacapone—Decreased appetite—Paclitaxel—ovarian cancer	0.000674	0.00071	CcSEcCtD
Entacapone—Dry mouth—Docetaxel—ovarian cancer	0.00067	0.000707	CcSEcCtD
Entacapone—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00067	0.000707	CcSEcCtD
Entacapone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000669	0.000706	CcSEcCtD
Entacapone—Fatigue—Paclitaxel—ovarian cancer	0.000668	0.000705	CcSEcCtD
Entacapone—Sweating—Epirubicin—ovarian cancer	0.000666	0.000702	CcSEcCtD
Entacapone—Pollakiuria—Doxorubicin—ovarian cancer	0.000666	0.000702	CcSEcCtD
Entacapone—Pain—Paclitaxel—ovarian cancer	0.000663	0.000699	CcSEcCtD
Entacapone—Constipation—Paclitaxel—ovarian cancer	0.000663	0.000699	CcSEcCtD
Entacapone—Haematuria—Epirubicin—ovarian cancer	0.000663	0.000698	CcSEcCtD
Entacapone—Confusional state—Docetaxel—ovarian cancer	0.000663	0.000698	CcSEcCtD
Entacapone—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000657	0.000693	CcSEcCtD
Entacapone—Oedema—Docetaxel—ovarian cancer	0.000657	0.000693	CcSEcCtD
Entacapone—Weight increased—Doxorubicin—ovarian cancer	0.000656	0.000692	CcSEcCtD
Entacapone—Epistaxis—Epirubicin—ovarian cancer	0.000656	0.000691	CcSEcCtD
Entacapone—Weight decreased—Doxorubicin—ovarian cancer	0.000652	0.000688	CcSEcCtD
Entacapone—Sinusitis—Epirubicin—ovarian cancer	0.000652	0.000687	CcSEcCtD
Entacapone—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000651	0.000686	CcSEcCtD
Entacapone—Agranulocytosis—Epirubicin—ovarian cancer	0.000649	0.000684	CcSEcCtD
Entacapone—Pneumonia—Doxorubicin—ovarian cancer	0.000647	0.000682	CcSEcCtD
Entacapone—Shock—Docetaxel—ovarian cancer	0.000647	0.000681	CcSEcCtD
Entacapone—Nervous system disorder—Docetaxel—ovarian cancer	0.000644	0.000679	CcSEcCtD
Entacapone—Thrombocytopenia—Docetaxel—ovarian cancer	0.000643	0.000678	CcSEcCtD
Entacapone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000639	0.000673	CcSEcCtD
Entacapone—Skin disorder—Docetaxel—ovarian cancer	0.000638	0.000673	CcSEcCtD
Entacapone—Bradycardia—Epirubicin—ovarian cancer	0.000635	0.000669	CcSEcCtD
Entacapone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000634	0.000668	CcSEcCtD
Entacapone—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00063	0.000664	CcSEcCtD
Entacapone—Haemoglobin—Epirubicin—ovarian cancer	0.000627	0.000661	CcSEcCtD
Entacapone—Anorexia—Docetaxel—ovarian cancer	0.000626	0.00066	CcSEcCtD
Entacapone—Urinary tract infection—Doxorubicin—ovarian cancer	0.000625	0.000659	CcSEcCtD
Entacapone—Conjunctivitis—Doxorubicin—ovarian cancer	0.000625	0.000659	CcSEcCtD
Entacapone—Haemorrhage—Epirubicin—ovarian cancer	0.000624	0.000658	CcSEcCtD
Entacapone—Hepatitis—Epirubicin—ovarian cancer	0.000624	0.000658	CcSEcCtD
Entacapone—Hypoaesthesia—Epirubicin—ovarian cancer	0.000621	0.000654	CcSEcCtD
Entacapone—Pharyngitis—Epirubicin—ovarian cancer	0.000619	0.000653	CcSEcCtD
Entacapone—Sweating—Doxorubicin—ovarian cancer	0.000616	0.00065	CcSEcCtD
Entacapone—Urinary tract disorder—Epirubicin—ovarian cancer	0.000616	0.000649	CcSEcCtD
Entacapone—Urticaria—Paclitaxel—ovarian cancer	0.000616	0.000649	CcSEcCtD
Entacapone—Hypotension—Docetaxel—ovarian cancer	0.000614	0.000647	CcSEcCtD
Entacapone—Haematuria—Doxorubicin—ovarian cancer	0.000613	0.000646	CcSEcCtD
Entacapone—Abdominal pain—Paclitaxel—ovarian cancer	0.000613	0.000646	CcSEcCtD
Entacapone—Body temperature increased—Paclitaxel—ovarian cancer	0.000613	0.000646	CcSEcCtD
Entacapone—Urethral disorder—Epirubicin—ovarian cancer	0.000612	0.000645	CcSEcCtD
Entacapone—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000608	0.000641	CcSEcCtD
Entacapone—Epistaxis—Doxorubicin—ovarian cancer	0.000607	0.000639	CcSEcCtD
Entacapone—Sinusitis—Doxorubicin—ovarian cancer	0.000603	0.000636	CcSEcCtD
Entacapone—Visual impairment—Epirubicin—ovarian cancer	0.000601	0.000634	CcSEcCtD
Entacapone—Agranulocytosis—Doxorubicin—ovarian cancer	0.0006	0.000633	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000599	0.000631	CcSEcCtD
Entacapone—Insomnia—Docetaxel—ovarian cancer	0.000594	0.000626	CcSEcCtD
Entacapone—Paraesthesia—Docetaxel—ovarian cancer	0.00059	0.000622	CcSEcCtD
Entacapone—Erythema multiforme—Epirubicin—ovarian cancer	0.00059	0.000622	CcSEcCtD
Entacapone—Bradycardia—Doxorubicin—ovarian cancer	0.000588	0.000619	CcSEcCtD
Entacapone—Dyspnoea—Docetaxel—ovarian cancer	0.000586	0.000618	CcSEcCtD
Entacapone—Somnolence—Docetaxel—ovarian cancer	0.000584	0.000616	CcSEcCtD
Entacapone—Eye disorder—Epirubicin—ovarian cancer	0.000583	0.000615	CcSEcCtD
Entacapone—Haemoglobin—Doxorubicin—ovarian cancer	0.00058	0.000612	CcSEcCtD
Entacapone—Cardiac disorder—Epirubicin—ovarian cancer	0.000579	0.00061	CcSEcCtD
Entacapone—Flushing—Epirubicin—ovarian cancer	0.000579	0.00061	CcSEcCtD
Entacapone—Dyspepsia—Docetaxel—ovarian cancer	0.000578	0.00061	CcSEcCtD
Entacapone—Haemorrhage—Doxorubicin—ovarian cancer	0.000577	0.000608	CcSEcCtD
Entacapone—Hepatitis—Doxorubicin—ovarian cancer	0.000577	0.000608	CcSEcCtD
Entacapone—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000574	0.000605	CcSEcCtD
Entacapone—Pharyngitis—Doxorubicin—ovarian cancer	0.000573	0.000604	CcSEcCtD
Entacapone—Decreased appetite—Docetaxel—ovarian cancer	0.000571	0.000602	CcSEcCtD
Entacapone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000571	0.000602	CcSEcCtD
Entacapone—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00057	0.000601	CcSEcCtD
Entacapone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000567	0.000598	CcSEcCtD
Entacapone—Fatigue—Docetaxel—ovarian cancer	0.000567	0.000597	CcSEcCtD
Entacapone—Urethral disorder—Doxorubicin—ovarian cancer	0.000566	0.000596	CcSEcCtD
Entacapone—Pain—Docetaxel—ovarian cancer	0.000562	0.000592	CcSEcCtD
Entacapone—Constipation—Docetaxel—ovarian cancer	0.000562	0.000592	CcSEcCtD
Entacapone—Visual impairment—Doxorubicin—ovarian cancer	0.000556	0.000586	CcSEcCtD
Entacapone—Asthenia—Paclitaxel—ovarian cancer	0.000556	0.000586	CcSEcCtD
Entacapone—Alopecia—Epirubicin—ovarian cancer	0.000551	0.000581	CcSEcCtD
Entacapone—Pruritus—Paclitaxel—ovarian cancer	0.000549	0.000578	CcSEcCtD
Entacapone—Mental disorder—Epirubicin—ovarian cancer	0.000547	0.000576	CcSEcCtD
Entacapone—Erythema multiforme—Doxorubicin—ovarian cancer	0.000546	0.000575	CcSEcCtD
Entacapone—Malnutrition—Epirubicin—ovarian cancer	0.000543	0.000572	CcSEcCtD
Entacapone—Feeling abnormal—Docetaxel—ovarian cancer	0.000542	0.000571	CcSEcCtD
Entacapone—Eye disorder—Doxorubicin—ovarian cancer	0.000539	0.000569	CcSEcCtD
Entacapone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000537	0.000566	CcSEcCtD
Entacapone—Cardiac disorder—Doxorubicin—ovarian cancer	0.000536	0.000565	CcSEcCtD
Entacapone—Flushing—Doxorubicin—ovarian cancer	0.000536	0.000565	CcSEcCtD
Entacapone—Flatulence—Epirubicin—ovarian cancer	0.000535	0.000564	CcSEcCtD
Entacapone—Tension—Epirubicin—ovarian cancer	0.000533	0.000562	CcSEcCtD
Entacapone—Dysgeusia—Epirubicin—ovarian cancer	0.000532	0.000561	CcSEcCtD
Entacapone—Diarrhoea—Paclitaxel—ovarian cancer	0.00053	0.000559	CcSEcCtD
Entacapone—Nervousness—Epirubicin—ovarian cancer	0.000527	0.000556	CcSEcCtD
Entacapone—Back pain—Epirubicin—ovarian cancer	0.000525	0.000554	CcSEcCtD
Entacapone—Muscle spasms—Epirubicin—ovarian cancer	0.000522	0.00055	CcSEcCtD
Entacapone—Body temperature increased—Docetaxel—ovarian cancer	0.000519	0.000548	CcSEcCtD
Entacapone—Abdominal pain—Docetaxel—ovarian cancer	0.000519	0.000548	CcSEcCtD
Entacapone—Dizziness—Paclitaxel—ovarian cancer	0.000513	0.00054	CcSEcCtD
Entacapone—Vision blurred—Epirubicin—ovarian cancer	0.000512	0.00054	CcSEcCtD
Entacapone—Alopecia—Doxorubicin—ovarian cancer	0.00051	0.000538	CcSEcCtD
Entacapone—Mental disorder—Doxorubicin—ovarian cancer	0.000506	0.000533	CcSEcCtD
Entacapone—Ill-defined disorder—Epirubicin—ovarian cancer	0.000504	0.000531	CcSEcCtD
Entacapone—Malnutrition—Doxorubicin—ovarian cancer	0.000503	0.00053	CcSEcCtD
Entacapone—Agitation—Epirubicin—ovarian cancer	0.000499	0.000526	CcSEcCtD
Entacapone—Flatulence—Doxorubicin—ovarian cancer	0.000495	0.000522	CcSEcCtD
Entacapone—Tension—Doxorubicin—ovarian cancer	0.000493	0.00052	CcSEcCtD
Entacapone—Vomiting—Paclitaxel—ovarian cancer	0.000493	0.00052	CcSEcCtD
Entacapone—Dysgeusia—Doxorubicin—ovarian cancer	0.000492	0.000519	CcSEcCtD
Entacapone—Malaise—Epirubicin—ovarian cancer	0.00049	0.000516	CcSEcCtD
Entacapone—Rash—Paclitaxel—ovarian cancer	0.000489	0.000515	CcSEcCtD
Entacapone—Dermatitis—Paclitaxel—ovarian cancer	0.000488	0.000515	CcSEcCtD
Entacapone—Nervousness—Doxorubicin—ovarian cancer	0.000488	0.000514	CcSEcCtD
Entacapone—Vertigo—Epirubicin—ovarian cancer	0.000488	0.000514	CcSEcCtD
Entacapone—Syncope—Epirubicin—ovarian cancer	0.000487	0.000513	CcSEcCtD
Entacapone—Leukopenia—Epirubicin—ovarian cancer	0.000486	0.000512	CcSEcCtD
Entacapone—Back pain—Doxorubicin—ovarian cancer	0.000486	0.000512	CcSEcCtD
Entacapone—Headache—Paclitaxel—ovarian cancer	0.000486	0.000512	CcSEcCtD
Entacapone—Hypersensitivity—Docetaxel—ovarian cancer	0.000484	0.00051	CcSEcCtD
Entacapone—Muscle spasms—Doxorubicin—ovarian cancer	0.000483	0.000509	CcSEcCtD
Entacapone—Palpitations—Epirubicin—ovarian cancer	0.00048	0.000506	CcSEcCtD
Entacapone—Loss of consciousness—Epirubicin—ovarian cancer	0.000477	0.000503	CcSEcCtD
Entacapone—Cough—Epirubicin—ovarian cancer	0.000474	0.0005	CcSEcCtD
Entacapone—Vision blurred—Doxorubicin—ovarian cancer	0.000474	0.000499	CcSEcCtD
Entacapone—Asthenia—Docetaxel—ovarian cancer	0.000471	0.000497	CcSEcCtD
Entacapone—Convulsion—Epirubicin—ovarian cancer	0.000471	0.000496	CcSEcCtD
Entacapone—Hypertension—Epirubicin—ovarian cancer	0.000469	0.000494	CcSEcCtD
Entacapone—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000466	0.000491	CcSEcCtD
Entacapone—Pruritus—Docetaxel—ovarian cancer	0.000465	0.00049	CcSEcCtD
Entacapone—Myalgia—Epirubicin—ovarian cancer	0.000462	0.000487	CcSEcCtD
Entacapone—Chest pain—Epirubicin—ovarian cancer	0.000462	0.000487	CcSEcCtD
Entacapone—Agitation—Doxorubicin—ovarian cancer	0.000462	0.000487	CcSEcCtD
Entacapone—Anxiety—Epirubicin—ovarian cancer	0.000461	0.000486	CcSEcCtD
Entacapone—Nausea—Paclitaxel—ovarian cancer	0.000461	0.000485	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000459	0.000484	CcSEcCtD
Entacapone—Discomfort—Epirubicin—ovarian cancer	0.000457	0.000482	CcSEcCtD
Entacapone—Malaise—Doxorubicin—ovarian cancer	0.000453	0.000478	CcSEcCtD
Entacapone—Dry mouth—Epirubicin—ovarian cancer	0.000452	0.000477	CcSEcCtD
Entacapone—Vertigo—Doxorubicin—ovarian cancer	0.000451	0.000476	CcSEcCtD
Entacapone—Syncope—Doxorubicin—ovarian cancer	0.000451	0.000475	CcSEcCtD
Entacapone—Leukopenia—Doxorubicin—ovarian cancer	0.00045	0.000474	CcSEcCtD
Entacapone—Diarrhoea—Docetaxel—ovarian cancer	0.00045	0.000474	CcSEcCtD
Entacapone—Confusional state—Epirubicin—ovarian cancer	0.000447	0.000471	CcSEcCtD
Entacapone—Palpitations—Doxorubicin—ovarian cancer	0.000444	0.000468	CcSEcCtD
Entacapone—Oedema—Epirubicin—ovarian cancer	0.000443	0.000467	CcSEcCtD
Entacapone—Loss of consciousness—Doxorubicin—ovarian cancer	0.000442	0.000466	CcSEcCtD
Entacapone—Cough—Doxorubicin—ovarian cancer	0.000439	0.000462	CcSEcCtD
Entacapone—Shock—Epirubicin—ovarian cancer	0.000436	0.00046	CcSEcCtD
Entacapone—Convulsion—Doxorubicin—ovarian cancer	0.000435	0.000459	CcSEcCtD
Entacapone—Nervous system disorder—Epirubicin—ovarian cancer	0.000435	0.000458	CcSEcCtD
Entacapone—Dizziness—Docetaxel—ovarian cancer	0.000435	0.000458	CcSEcCtD
Entacapone—Thrombocytopenia—Epirubicin—ovarian cancer	0.000434	0.000457	CcSEcCtD
Entacapone—Hypertension—Doxorubicin—ovarian cancer	0.000434	0.000457	CcSEcCtD
Entacapone—Skin disorder—Epirubicin—ovarian cancer	0.000431	0.000454	CcSEcCtD
Entacapone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000428	0.000452	CcSEcCtD
Entacapone—Chest pain—Doxorubicin—ovarian cancer	0.000428	0.000451	CcSEcCtD
Entacapone—Myalgia—Doxorubicin—ovarian cancer	0.000428	0.000451	CcSEcCtD
Entacapone—Anxiety—Doxorubicin—ovarian cancer	0.000426	0.000449	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000425	0.000448	CcSEcCtD
Entacapone—Discomfort—Doxorubicin—ovarian cancer	0.000423	0.000446	CcSEcCtD
Entacapone—Anorexia—Epirubicin—ovarian cancer	0.000423	0.000445	CcSEcCtD
Entacapone—Dry mouth—Doxorubicin—ovarian cancer	0.000418	0.000441	CcSEcCtD
Entacapone—Vomiting—Docetaxel—ovarian cancer	0.000418	0.00044	CcSEcCtD
Entacapone—Rash—Docetaxel—ovarian cancer	0.000414	0.000437	CcSEcCtD
Entacapone—Hypotension—Epirubicin—ovarian cancer	0.000414	0.000437	CcSEcCtD
Entacapone—Dermatitis—Docetaxel—ovarian cancer	0.000414	0.000436	CcSEcCtD
Entacapone—Confusional state—Doxorubicin—ovarian cancer	0.000414	0.000436	CcSEcCtD
Entacapone—Headache—Docetaxel—ovarian cancer	0.000412	0.000434	CcSEcCtD
Entacapone—Oedema—Doxorubicin—ovarian cancer	0.00041	0.000432	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000404	0.000426	CcSEcCtD
Entacapone—Shock—Doxorubicin—ovarian cancer	0.000403	0.000425	CcSEcCtD
Entacapone—Nervous system disorder—Doxorubicin—ovarian cancer	0.000402	0.000424	CcSEcCtD
Entacapone—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000402	0.000423	CcSEcCtD
Entacapone—Insomnia—Epirubicin—ovarian cancer	0.000401	0.000423	CcSEcCtD
Entacapone—Skin disorder—Doxorubicin—ovarian cancer	0.000398	0.00042	CcSEcCtD
Entacapone—Paraesthesia—Epirubicin—ovarian cancer	0.000398	0.00042	CcSEcCtD
Entacapone—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000396	0.000418	CcSEcCtD
Entacapone—Dyspnoea—Epirubicin—ovarian cancer	0.000395	0.000417	CcSEcCtD
Entacapone—Somnolence—Epirubicin—ovarian cancer	0.000394	0.000415	CcSEcCtD
Entacapone—Anorexia—Doxorubicin—ovarian cancer	0.000391	0.000412	CcSEcCtD
Entacapone—Nausea—Docetaxel—ovarian cancer	0.00039	0.000411	CcSEcCtD
Entacapone—Dyspepsia—Epirubicin—ovarian cancer	0.00039	0.000411	CcSEcCtD
Entacapone—Decreased appetite—Epirubicin—ovarian cancer	0.000385	0.000406	CcSEcCtD
Entacapone—Hypotension—Doxorubicin—ovarian cancer	0.000383	0.000404	CcSEcCtD
Entacapone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000383	0.000403	CcSEcCtD
Entacapone—Fatigue—Epirubicin—ovarian cancer	0.000382	0.000403	CcSEcCtD
Entacapone—Pain—Epirubicin—ovarian cancer	0.000379	0.0004	CcSEcCtD
Entacapone—Constipation—Epirubicin—ovarian cancer	0.000379	0.0004	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000374	0.000394	CcSEcCtD
Entacapone—Insomnia—Doxorubicin—ovarian cancer	0.000371	0.000391	CcSEcCtD
Entacapone—Paraesthesia—Doxorubicin—ovarian cancer	0.000368	0.000388	CcSEcCtD
Entacapone—Dyspnoea—Doxorubicin—ovarian cancer	0.000366	0.000385	CcSEcCtD
Entacapone—Feeling abnormal—Epirubicin—ovarian cancer	0.000365	0.000385	CcSEcCtD
Entacapone—Somnolence—Doxorubicin—ovarian cancer	0.000365	0.000384	CcSEcCtD
Entacapone—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000362	0.000382	CcSEcCtD
Entacapone—Dyspepsia—Doxorubicin—ovarian cancer	0.000361	0.000381	CcSEcCtD
Entacapone—Decreased appetite—Doxorubicin—ovarian cancer	0.000357	0.000376	CcSEcCtD
Entacapone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000354	0.000373	CcSEcCtD
Entacapone—Fatigue—Doxorubicin—ovarian cancer	0.000354	0.000373	CcSEcCtD
Entacapone—Urticaria—Epirubicin—ovarian cancer	0.000352	0.000371	CcSEcCtD
Entacapone—Pain—Doxorubicin—ovarian cancer	0.000351	0.00037	CcSEcCtD
Entacapone—Constipation—Doxorubicin—ovarian cancer	0.000351	0.00037	CcSEcCtD
Entacapone—Abdominal pain—Epirubicin—ovarian cancer	0.00035	0.000369	CcSEcCtD
Entacapone—Body temperature increased—Epirubicin—ovarian cancer	0.00035	0.000369	CcSEcCtD
Entacapone—Feeling abnormal—Doxorubicin—ovarian cancer	0.000338	0.000356	CcSEcCtD
Entacapone—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000335	0.000353	CcSEcCtD
Entacapone—Hypersensitivity—Epirubicin—ovarian cancer	0.000327	0.000344	CcSEcCtD
Entacapone—Urticaria—Doxorubicin—ovarian cancer	0.000326	0.000343	CcSEcCtD
Entacapone—Abdominal pain—Doxorubicin—ovarian cancer	0.000324	0.000342	CcSEcCtD
Entacapone—Body temperature increased—Doxorubicin—ovarian cancer	0.000324	0.000342	CcSEcCtD
Entacapone—Asthenia—Epirubicin—ovarian cancer	0.000318	0.000335	CcSEcCtD
Entacapone—Pruritus—Epirubicin—ovarian cancer	0.000314	0.000331	CcSEcCtD
Entacapone—Diarrhoea—Epirubicin—ovarian cancer	0.000303	0.00032	CcSEcCtD
Entacapone—Hypersensitivity—Doxorubicin—ovarian cancer	0.000302	0.000318	CcSEcCtD
Entacapone—Asthenia—Doxorubicin—ovarian cancer	0.000294	0.00031	CcSEcCtD
Entacapone—Dizziness—Epirubicin—ovarian cancer	0.000293	0.000309	CcSEcCtD
Entacapone—Pruritus—Doxorubicin—ovarian cancer	0.00029	0.000306	CcSEcCtD
Entacapone—Vomiting—Epirubicin—ovarian cancer	0.000282	0.000297	CcSEcCtD
Entacapone—Diarrhoea—Doxorubicin—ovarian cancer	0.000281	0.000296	CcSEcCtD
Entacapone—Rash—Epirubicin—ovarian cancer	0.000279	0.000295	CcSEcCtD
Entacapone—Dermatitis—Epirubicin—ovarian cancer	0.000279	0.000294	CcSEcCtD
Entacapone—Headache—Epirubicin—ovarian cancer	0.000278	0.000293	CcSEcCtD
Entacapone—Dizziness—Doxorubicin—ovarian cancer	0.000271	0.000286	CcSEcCtD
Entacapone—Nausea—Epirubicin—ovarian cancer	0.000263	0.000278	CcSEcCtD
Entacapone—Vomiting—Doxorubicin—ovarian cancer	0.000261	0.000275	CcSEcCtD
Entacapone—Rash—Doxorubicin—ovarian cancer	0.000259	0.000273	CcSEcCtD
Entacapone—Dermatitis—Doxorubicin—ovarian cancer	0.000258	0.000272	CcSEcCtD
Entacapone—Headache—Doxorubicin—ovarian cancer	0.000257	0.000271	CcSEcCtD
Entacapone—Nausea—Doxorubicin—ovarian cancer	0.000244	0.000257	CcSEcCtD
